Leading Edge Precision Diagnostic Capabilities now available in the EU
Through a new and innovative collaboration with Genomic Testing Cooperative lca (GTC), a leading edge provider of Next Generation Sequencing [NGS]diagnostic test services based in California, USA, we are excited to be able to offer the following NGS diagnostic test services from our partner company to improve cancer care for our customers through the deployment of precision diagnostic capabilities here in the EU:
- Solid Tumor Profile Plus
(comprehensive DNA and RNA analyses done with FFPE (formalin-fixed, paraffin embedded) blocks for patients with solid tumors)
- Liquid Biopsy Solid Tumor Profile
(comprehensive DNA analysis done with blood samples for patients with solid tumors)
- Hematology Profile Plus
(comprehensive DNA and RNA analyses done with blood samples, bone marrow, fresh tissue or FFPE samples for patients with hematological tumors)
- Liquid Biopsy Hematology Profile
(comprehensive DNA done with blood samples for patients with hematological tumors)
Solid Tumor Profile Plus, Liquid Biopsy Solid Tumor Profile, Hematology Profile Plus, Liquid Biopsy Hematology Profile are CE certified in vitro diagnostic medical devices in conformity with directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices.
The tests are available now and can be ordered by physicians and patients.
Please contact TherapySelect for product, pricing and ordering inquiries.
Our website will be further updated with enhanced detail on these new and exciting services in the near future but in the meantime if you have any immediate queries please do not hesitate to get in contact.